Evidence network for deaths_(OS)

2POPLAR, 2016 OAK (all population), 20161CheckMate 078, 20191JAVELIN Lung 200 (all population), 2018atezolizumab alone vs. avelumab alone 0.88 [0.70; 1.09]0.88 [0.70;1.09]atezolizumab alone vs. avelumab alone 0.88 [0.70; 1.09]atezolizumab alone vs. docetaxel atezolizumab alone better 0.79 [0.70; 0.89]0.79 [0.70;0.89]atezolizumab alone vs. docetaxel atezolizumab alone better 0.79 [0.70; 0.89]atezolizumab alone vs. nivolumab alone 1.16 [0.86; 1.57]1.16 [0.86;1.57]atezolizumab alone vs. nivolumab alone 1.16 [0.86; 1.57]avelumab alone vs. atezolizumab alone 1.14 [0.92; 1.42]1.14 [0.92;1.42]avelumab alone vs. atezolizumab alone 1.14 [0.92; 1.42]avelumab alone vs. docetaxel 0.90 [0.75; 1.08]0.90 [0.75;1.08]avelumab alone vs. docetaxel 0.90 [0.75; 1.08]avelumab alone vs. nivolumab alone 1.32 [0.95; 1.84]1.32 [0.95;1.84]avelumab alone vs. nivolumab alone 1.32 [0.95; 1.84]docetaxel vs. atezolizumab alone atezolizumab alone better 1.27 [1.12; 1.44]1.27 [1.12;1.44]docetaxel vs. atezolizumab alone atezolizumab alone better 1.27 [1.12; 1.44]docetaxel vs. avelumab alone 1.11 [0.93; 1.33]1.11 [0.93;1.33]docetaxel vs. avelumab alone 1.11 [0.93; 1.33]docetaxel vs. nivolumab alone nivolumab alone better 1.47 [1.12; 1.93]1.47 [1.12;1.93]docetaxel vs. nivolumab alone nivolumab alone better 1.47 [1.12; 1.93]nivolumab alone vs. atezolizumab alone 0.86 [0.64; 1.17]0.86 [0.64;1.17]nivolumab alone vs. atezolizumab alone 0.86 [0.64; 1.17]nivolumab alone vs. avelumab alone 0.76 [0.54; 1.05]0.76 [0.54;1.05]nivolumab alone vs. avelumab alone 0.76 [0.54; 1.05]nivolumab alone vs. docetaxel nivolumab alone better 0.68 [0.52; 0.89]0.68 [0.52;0.89]nivolumab alone vs. docetaxel nivolumab alone better 0.68 [0.52; 0.89]docetaxelatezolizumab alonenivolumab aloneavelumab aloneTislelizumabdirect evidencenetwork meta-analysis
T vs. C docetaxelatezolizumab alonenivolumab aloneavelumab aloneTislelizumab
docetaxel---1.27
1.12; 1.44		1.47
1.12; 1.93		1.11
0.93; 1.33		NA
atezolizumab alone0.79
0.70; 0.89		---1.16
0.86; 1.57		0.88
0.70; 1.09		NA
nivolumab alone0.68
0.52; 0.89		0.86
0.64; 1.17		---0.76
0.54; 1.05		NA
avelumab alone0.90
0.75; 1.08		1.14
0.92; 1.42		1.32
0.95; 1.84		---NA
TislelizumabNANANANA---

pathologies: 37 - treatments: 940 result logic

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons